Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Cannabinoids vs other anti‐emetic agent

Withdrawals due to adverse events · people with chemotherapy‐induced nausea and vomiting

Cannabinoids may leads to higher withdrawal due to adverse event ( compared with other anti‐emetic agent (low certainty).

1 finding from 1 review

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy 2015 · Cochrane Headline outcomes only
RR 3.2 [1.3, 8]
6 studies · 740 participants
Low

Cannabinoids vs placebo

Withdrawals due to adverse events · people with chemotherapy‐induced nausea and vomiting

It is very uncertain whether cannabinoids changes withdrawal due to adverse event ( compared with placebo (very low certainty).

1 finding from 1 review

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy 2015 · Cochrane Headline outcomes only
RR 6.9 [1.96, 24]
2 studies · 276 participants
Very low

Cannabinoid plus other anti‐emetic agent vs other anti‐emetic monotherapy

Withdrawals due to adverse events · people with chemotherapy‐induced nausea and vomiting

It is very uncertain whether cannabinoid plus other anti‐emetic agent changes withdrawal due to adverse event ( compared with other anti‐emetic monotherapy (very low certainty).

1 finding from 1 review

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy 2015 · Cochrane Headline outcomes only
RR 7 [0.88, 55]
2 studies · 105 participants
Very low